Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

1315 Capital

Investor type Private Equity Firm
Founders Adele C. Oliva Michael Koby


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 8
Average round size
The average size of a deal this fund participated in
Portfolio companies 6
Rounds per year 1.00
Lead investments 2
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees 4
Stages of investment
Private Equity

Areas of investment

  • Pharmaceutical
  • Medical Device
  • Health Care
  • Medical
  • Beauty

1315 Capital appeared to be the VC, which was created in 2014. The main office of represented VC is situated in the Philadelphia. The fund was located in North America if to be more exact in United States.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Colorescience, Onkos Surgical, Encore Dermatology The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Cosmetics, Medical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The typical startup value when the investment from 1315 Capital is 50-100 millions dollars. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. Opposing the other organizations, this 1315 Capital works on 9 percentage points less the average amount of lead investments. Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2012. The fund is constantly included in less than 2 deals per year.

The fund was created by Adele C. Oliva, Michael Koby. Besides them, we counted 4 critical employees of this fund in our database.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the 1315 Capital, startups are often financed by Split Rock Partners, Montreux Equity Partners, Longwood Founders Fund. The meaningful sponsors for the fund in investment in the same round are Montreux Equity Partners, Longitude Capital, Horizon Technology Finance. In the next rounds fund is usually obtained by Canaan Partners, 3D Systems.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of 1315 Capital:
Typical Co-investors
1315 Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after 1315 Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Advantage Risk Management Japan, Tokyo
Aggreko Glasgow, Glasgow City, United Kingdom
Avic Securities China, Guangdong, Jiangxi
China Capital Zhongcai Fund Management China, Tianjin, Wuqing
Economic Development of Canada Canada, Quebec, Val-d'or
First European American Ventures -
Innovative Connections Inc. -
Internexus S.A -
Jaunt California, San Mateo, United States
Jobs 4 NSW Australia, New South Wales, Sydney
MetTel New York, New York, United States
Rathbone Greenbank Bristol, England, United Kingdom
Shenglong Capital Beijing, China, Shunyi
SP Investment Associates (SPIA) -
The Wallace H. Coulter Foundation Florida, Miami, United States
Veturi Venture Accelerator Espoo, Finland, Uusimaa
Xinjiang Xinxi Guquan Touzi China, Ürümqi, Xinjiang
Yizhuo Wangluo China, Jiading District
Yunnan Huizhong Fund -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
Machine Learning
$25M13 Jul 2022 Chicago, Illinois, United States

Onkos Surgical

Health Care
Medical Device
$22M01 Sep 2021 New Jersey, United States

Encore Dermatology

Health Care
Medical Device
$20M08 Apr 2019 Pennsylvania, United States


Cosmetic Surgery
Medical Device
$25M09 Nov 2017 New York, United States


$15M21 Jul 2017 Carlsbad, California, United States

Onkos Surgical

Health Care
Medical Device
$17M19 Apr 2017 New Jersey, United States

JDS Therapeutics LLC

Natural Resources
$16M31 Oct 2015 New York, United States

Onkos Surgical

Health Care
Medical Device
06 Oct 2015 New Jersey, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent 1315 Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: